Insufflation Devices Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

The Insufflation Devices Market is Segmented by Application (Laparoscopic, Endoscopic, and Others), End-users (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East, Africa, and South America). The report offers the value (USD million) for the above segments.

Market Snapshot

Insufflation Devices Market Size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The insufflation devices market is projected to register a CAGR of 6.3% during the forecast period (2022-2027).

The COVID-19 epidemic and the resulting restrictions have altered how healthcare systems operate worldwide. The continuing "coronavirus disease 19" (COVID-19) pandemic has had a significant impact on surgical care delivery around the world. Elective operations have been postponed to devote more resources to COVID-19 patients. According to a research article published in July 2021 titled "Impact of the COVID-19 Pandemic on the Patient's Decision about Bariatric Surgery: Results of a National Survey," bariatric operations were withdrawn in most countries after the International Federation for the Surgery of Obesity, and Metabolic Disorders issued recommendations (IFSO). Approximately 60,000 bariatric procedures per month may have been postponed globally. After a few months, several governments have begun to ease restrictions, such as reopening businesses and public areas, permitting social interaction, and allowing elective surgery to resume. As a result, COVID-19 significantly impacted the market for insufflation devices at the start of the pandemic.

Due to technological developments in surgery, an increase in the number of surgical cases, and an increase in the frequency of uterine fibroids, obesity, and cardiac diseases around the world, the need for insufflation devices is rising. One of the major factors driving market expansion is the rising incidence of obesity due to a sedentary lifestyle and an increase in the consumption of energy-dense meals high in fat and sugar. According to the Trust for America's Health, the adult obesity rate in the United States reached 42.4 percent in 2020, marking the first time the national percentage exceeded 40%.

As insufflation devices are used in bariatric surgery, the rising prevalence of obese persons with a BMI of 35-39 who have certain major health concerns, such as type 2 diabetes, sleep apnea, and high blood pressure, is a high-impact driver of the market. The number of bariatric procedures performed grew from 158,000 in 2011 to 256,000 in 2019, according to the American Society for Metabolic and Bariatric Surgery (ASMBS). Furthermore, as the public becomes more aware of the benefits of bariatric surgery, the demand for insufflation devices as a treatment option has grown.

Scope of the Report

As per the scope of this report, insufflation is the act of blowing gas, powder, or vapor into a body cavity. Gases are often insufflated into a body cavity to inflate the cavity for more workroom during various surgery. The Insufflation Devices Market is Segmented by Application (Laparoscopic, Endoscopic, and Others), End-users (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Laparoscopic Surgery Segment is Expected to Hold a Major Market Share in the Insufflation Devices Market

The laparoscopic surgery segment is projected to grow significantly over the forecast period. Insufflation devices are predicted to rise as the number of laparoscopic procedures conducted worldwide increases due to their benefits. Every year, about 13 million laparoscopic surgeries are performed worldwide, according to the Cleveland Clinic 2022. Over the next five years, these figures are expected to rise by 1%. Laparoscopic surgery is widely used in high-risk patients, such as the elderly, obese patients, and those with preexisting illnesses such as cardiovascular and pulmonary problems. According to the Center for Disease Control and Prevention (CDC) 2020, over 600,000 hysterectomies are performed in the United States each year, and approximately 20 million women in the United States have undergone a hysterectomy. Insufflation devices are projected to be in more demand due to such occurrences.

The segment is being driven by an increase in the use of laparoscopic surgical methods such as laparoscopic cholecystectomy, hernia repair, laparoscopic splenectomy, and hepatectomy worldwide. A few advantages of laparoscopic surgery are a few advantages of reduced postoperative pain, superior cosmetic results, increased patient satisfaction, and a shorter hospital stay. There has also been an increase in the number of laparoscopic emergency operations. Because insufflation devices are commonly employed in laparoscopic procedures, such factors are projected to propel the market forward, thereby boosting the market growth.

Insufflation Devices Market Research

North America is Expected to Hold a significant share in the market and is expected to do the Same in the Forecast Period.

Obesity has quickly become a major public health concern. Obesity's economic impact grows in lockstep with its prevalence, owing to both direct and indirect expenditures. The COVID-19 pandemic has negatively influenced obesity, lowering access to bariatric care and treatment of obesity-related disorders while also generating an increasingly obesogenic atmosphere.

North America's market is rising due to its developed healthcare infrastructure, growing demand for innovative technical solutions, and the considerable presence of leading industry participants. In addition, the region's growing desire for less invasive surgeries is expected to enhance the market growth. Access is necessary to allow tools to be inserted into the abdomen during a minimally invasive surgical procedure in the abdomen, such as gallbladder removal.

Technological advances are also helping to drive the market in North America forward. For example, Stryker's 45L PneumoSure XL insufflator offers remarkable performance and improved safety and reliability. Bariatrics and Vessel Harvesting are two additional modes included. This insufflator also includes real-time pressure sensing for improved precision during procedures, but this feature requires special insufflation tubing. The ability of the PneumoSure to maintain pneumoperitoneum under the most extreme situations, along with a fully integrated color touch screen, makes it easier to use in any operating room worldwide. Northgate Technologies, Inc. (NTI) also announced in October 2019 that Vizient, Inc., the biggest member-driven healthcare performance improvement organization in the country, was awarded their NEBULAE I System, High-flow Laparoscopic Insufflator, an Innovative Technology contract. The contract was awarded a NEBULAE I System recommendation from hospital professionals in this field who serve on one of Vizient's member-led councils. Hence, all the abovementioned factors are projected to boost the market’s growth.

Insufflation Devices Market Growth

Competitive Landscape

The insufflation device market is fragmented and competitive and consists of several major players. Some players operating in the market are STERIS, COMEG, Stryker, B. Braun Medical Ltd, CONMED Corporation, Karl Storz, Olympus, Koninklijke Philips N.V., Bracco Diagnostics Inc., Meditech Systems Ltd, Medtronic, FUJIFILM Holdings America Corporation, Smith & Nephew, and Richard Wolf.

Recent Developments

· In July 2021, Palliare secured 510(k) clearance from the United States Food and Drug Administration (FDA) to extend the usage of its EVA15 insufflation technology in endoscopic surgery. The approval enables to use END-200 tubeset to expand the potential of EVA15 continuous pressure insufflation technology from laparoscopic surgery to endoscopic and endoluminal surgery.

· In June 2021, Palliare closed an oversubscribed USD 8 million Series A investment round. Seroba Life Sciences, a leading European Life Sciences Venture Capital firm, led the round, which included Luxembourg-based SCM AD Ventures, the Western Development Commission, and several individual investors. The money will be utilized to support Palliare's EVA15 insufflator and smoke evacuation system commercial launch activities in the United States and additional R&D activities.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Global Increase in the Prevalence of Laparoscopic Procedures

      2. 4.2.2 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Gas insufflation-related complications

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD million)

    1. 5.1 By Application

      1. 5.1.1 Laproscopic Surgery

      2. 5.1.2 Endoscopic Surgery

      3. 5.1.3 Others

    2. 5.2 By End Use

      1. 5.2.1 Hospitals

      2. 5.2.2 Clinics

      3. 5.2.3 Ambulatory Surgical Center

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 STERIS

      2. 6.1.2 COMEG

      3. 6.1.3 Stryker

      4. 6.1.4 B. Braun Medical Ltd

      5. 6.1.5 CONMED Corporation

      6. 6.1.6 Karl Storz

      7. 6.1.7 Olympus

      8. 6.1.8 Koninklijke Philips N.V.

      9. 6.1.9 Bracco Diagnostics Inc.

      10. 6.1.10 Baptist Health

      11. 6.1.11 Medtronic

      12. 6.1.12 FUJIFILM Holdings America Corporation

      13. 6.1.13 Smith & Nephew

      14. 6.1.14 Richard Wolf

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Insufflation Devices Market market is studied from 2019 - 2027.

The Global Insufflation Devices Market is growing at a CAGR of 6.3% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Medtronic , STERIS , Stryker, Smith & Nephew, Karl Storz are the major companies operating in Global Insufflation Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!